Meeting
2019 ASCO-SITC Clinical Immuno-Oncology Symposium
Isolation and characterization of exosomes from IDH mutant gliomas.
Authors
Nils Ludwig
Department of Pathology, University of Pittsburgh School of Medicine, Pittsburgh, PA
Nils Ludwig, Aparna Rao, Saigopalakrishna Saileelaprasad Yerneni, Nduka Amankulor, Theresa Whiteside
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session B
Track
Breast and Gynecologic Cancers,Developmental Therapeutics,Genitourinary Cancer,Head and Neck Cancer,Lung Cancer,Melanoma/Skin Cancers,Gastrointestinal Cancer,Combination Studies,Implications for Patients and Society,Miscellaneous Cancers,Hematologic Malignancies
Sub Track
Biomarkers and Inflammatory Signatures
Citation
J Clin Oncol 37, 2019 (suppl 8; abstr 152)
DOI
10.1200/JCO.2019.37.8_suppl.152
Abstract #
152
Poster Bd #
G6
Abstract Disclosures
Similar Posters
Poster
2019 ASCO Annual Meeting
Study of tumor infiltrating immune CELLS and vasculature in human gliomas: Differences in IDH1/2 mutant versus IDH1/2WT tumors.
First Author: Maria Cruz Martin Soberón
Poster
2019 ASCO Annual Meeting
Survival outcomes in glioma patients with noncanonical IDH mutations: Beyond diagnostic improvements.
First Author: Enrico Franceschi
Poster
2017 ASCO Annual Meeting
Comprehensive assessment of ATRX mutation, protein expression, and alternative lengthening of telomeres (ALT) phenotype in grade II and III gliomas.
First Author: Aline P. Becker
Poster
2024 ASCO Annual Meeting
Deep immune profiling of intrahepatic cholangiocarcinoma with CODEX multiplexed imaging.
First Author: Soumya Shekhar